Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-01-13EMA Authorised: Welireg (belzutifan) — Merck Sharp & Dohme B.V.
The European Medicines Agency authorised Welireg (belzutifan) for renal cell carcinoma and von Hippel-Lindau disease, in the EU under condit…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Retifanlimab and Ruxolitinib In Solid Malignancies [Phase 1, Phase 2]
A Phase 1/2 trial of retifanlimab and ruxolitinib in solid malignancies is currently recruiting, including non-small cell lung cancer and re…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases [Phase 2]
Phase II clinical trial evaluating stereotactic radiotherapy for oligoprogressive metastases in metastatic renal cell carcinoma; currently r…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers [Phase 1, Phase 2]
A Phase 1/2 study of OC-001 in locally advanced or metastatic cancers has been terminated according to its clinical trials registry listing.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Predicting HIF-2α Levels in Clear Cell Kidney Cancer Using Machine Learning
A clinical trial from the First Affiliated Hospital of Fujian Medical University aims to predict HIF-2α levels in renal cell carcinoma (clea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC) [NA]
This ClinicalTrials.gov entry outlines a study on consolidative metastasis and primary directed therapy (MPDT) for renal cell carcinoma, whi…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating cabozantinib or sunitinib malate in patients with metastatic variant histology renal cell carcinoma, inclu…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer [Phase 2]
A Phase 2 clinical trial update evaluating ixazomib, gemcitabine, and doxorubicin in locally advanced or metastatic renal cell carcinoma, in…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: The Cold Ischemia Robot-assisted Partial Nephrectomy [NA]
This clinical trial update notes ongoing recruitment for a robotic, cold-ischemia partial nephrectomy to treat renal cell carcinoma.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Multicenter Real-World Study on TKI Therapy After Progression on First-Line TKI/IO Therapy or TKI/IO Therapy After Progression on First-Line TKI in Chinese Patients With Metastatic Renal Cell Carcinoma (mRCC)
Clinical trial assessing second-line TKI therapy in Chinese patients with metastatic renal cell carcinoma after progression on first-line TK…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery [EARLY_Phase 1]
An early-phase trial evaluating nivolumab with or without bevacizumab or ipilimumab before surgery in patients with resectable metastatic re…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Radical Nephrectomy With vs Without Template Lymph Node Dissection in High-Risk Renal Cell Carcinoma (T-LND RCC): A Randomized Clinical Trial [NA]
The document outlines a randomized clinical trial comparing radical nephrectomy with template lymph node dissection versus without it in hig…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers [Phase 1]
Phase 1 study assessing safety and early efficacy of KFA115 alone and in combination with pembrolizumab in select advanced cancers; the tria…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell Carcinoma [NA]
This entry notes a post-marketing surveillance study of PROSENSE cryotherapy for renal cell carcinoma, with the study status ACTIVE_NOT_RECR…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma [Phase 2]
A Phase 2 clinical trial is evaluating PET-guided stereotactic body radiation therapy for oligoprogressive disease in non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Navigated Partial Nephrectomy [NA]
This entry notes the completion of a clinical trial evaluating navigated partial nephrectomy for renal cancer.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative
A prospective registry and translational research initiative on TFE renal cell carcinoma, sponsored by Children's Hospital Medical Center, C…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: PET/MR for Characterization of Renal Masses (RMs)
Clinical trial evaluating PET/MR imaging to characterize renal masses is currently recruiting, including renal cell carcinoma and benign ren…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
An observational basket trial sponsored by Elephas aims to collect tissue to develop and train a live tumor diagnostic platform across multi…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer [Phase 2]
Phase 2 trial evaluating stereotactic ablative body radiation therapy for patients with primary renal cell carcinoma. The current status is …
-
CLINICAL_TRIALS withdrawal · 2025-12-24Clinical Trial Update: STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma [Phase 1]
A Phase 1 study of STIL101 for injection across pancreatic ductal adenocarcinoma, colorectal cancer, renal cell carcinoma, cervical cancer, …
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma [NA]
A clinical trial is evaluating the diagnostic value of a novel PET molecular imaging agent for renal cell carcinoma and is currently recruit…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Advantage of a Fast-recovery Protocol for Minimally Invasive Kidney Surgery
A clinical trial update notes completion of a study evaluating a fast-recovery protocol for minimally invasive kidney surgery in renal cell …
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Pre-Surgical Sutent in Renal Cell Carcinoma (RCC) [Phase 2]
An update on a Phase 2 trial of pre-surgical sunitinib (Sutent) for renal cell carcinoma. The study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY) [NA]
This entry provides an update on the ongoing clinical trial NCT05820087 evaluating the Edison system from HistoSonics for treating primary s…